See more : Midwest Energy Emissions Corp. (MEEC) Income Statement Analysis – Financial Results
Complete financial analysis of Formycon AG (FYB.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Formycon AG, a leading company in the Biotechnology industry within the Healthcare sector.
- Star Fashion Culture Holdings Limited (STFS) Income Statement Analysis – Financial Results
- Parkit Enterprise Inc. (PKTEF) Income Statement Analysis – Financial Results
- TGB Banquets and Hotels Limited (TGBHOTELS.NS) Income Statement Analysis – Financial Results
- Kyowakogyosyo Co.,Ltd. (5971.T) Income Statement Analysis – Financial Results
- Umuthi Healthcare Solutions Plc (UHS.L) Income Statement Analysis – Financial Results
Formycon AG (FYB.DE)
About Formycon AG
Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease and ulcerative colitis, which is in the Phase III clinical trial; and FYB203, a biosimilar candidate for Eylea to treat neovascular age-related macular degeneration and other eye diseases that is in Phase III clinical trials. The company is also developing FYB206; and FYB207, an antiviral drug for the treatment of COVID-19. It has a collaboration agreement with Leukocare AG to develop stable formulations for various candidates in its product pipeline. The company was formerly known as Nanohale AG and changed its name to Formycon AG in 2012. Formycon AG was founded in 1999 and is headquartered in Planegg, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 77.70M | 42.50M | 36.61M | 34.23M | 33.16M | 42.99M | 29.00M | 19.53M | 16.92M | 12.59M | 276.17K | 138.43K | 0.00 | 49.25K | 20.00K |
| Cost of Revenue | 54.39M | 30.43M | 26.50M | 36.41M | 32.19M | 24.27M | 20.75M | 15.39M | 8.88M | 5.91M | 1.49M | 84.61K | 34.00K | 6.74K | 23.00K |
| Gross Profit | 23.31M | 12.07M | 10.11M | -2.19M | 962.44K | 18.73M | 8.25M | 4.15M | 8.04M | 6.68M | -1.21M | 53.82K | -34.00K | 42.51K | -3.00K |
| Gross Profit Ratio | 30.00% | 28.41% | 27.61% | -6.39% | 2.90% | 43.55% | 28.46% | 21.22% | 47.53% | 53.05% | -439.89% | 38.88% | 0.00% | 86.31% | -15.00% |
| Research & Development | 9.16M | 16.91M | 16.81M | 40.95M | 35.35M | 36.64M | 0.00 | 0.00 | 0.00 | 10.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 13.28M | 11.45M | 6.53M | 5.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 492.35K | 359.30K | 0.00 | 0.00 |
| Selling & Marketing | 841.00K | 1.44M | 600.00K | 702.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 75.38K | 399.20K | 0.00 | 0.00 |
| SG&A | 14.57M | 12.89M | 7.13M | -37.05M | -31.41M | 7.93M | 6.33M | 5.12M | 3.86M | 2.89M | 2.91M | 567.73K | 758.50K | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 345.34K | 703.38K | 113.57K | 0.00 | -2.85K | -1.44K | 0.00 | 6.53M | 1.94M | 563.60K | 1.06M | 188.00K |
| Operating Expenses | 23.67M | 29.80M | 23.94M | 3.55M | 3.23M | 11.60M | 9.79M | 8.22M | 7.51M | 5.81M | 6.53M | 2.51M | 1.32M | 1.06M | 188.00K |
| Cost & Expenses | 78.07M | 60.23M | 50.44M | 39.97M | 35.43M | 35.87M | 30.54M | 23.61M | 16.39M | 11.72M | 8.02M | 2.60M | 1.36M | 1.07M | 211.00K |
| Interest Income | 2.82M | 302.00K | 2.00K | 1.93K | 2.68K | 27.46K | 40.72K | 8.48K | 46.29K | 7.42K | 7.40K | 161.53K | 71.00K | 11.27K | 0.00 |
| Interest Expense | 94.00K | 143.00K | 173.00K | 30.00K | 28.25K | 32.96K | 42.10K | 24.72K | 25.20K | 7.58K | 2.04K | 25.58K | 5.00K | 719.65 | 0.00 |
| Depreciation & Amortization | 1.89M | 1.86M | 1.61M | 915.22K | 911.91K | 904.28K | 784.77K | 698.88K | 934.80K | 1.07M | 1.10M | 394.00K | 59.00K | 14.48K | 7.15K |
| EBITDA | 81.05M | 51.53M | -12.42M | -5.90M | -1.36M | 8.02M | -751.50K | -3.34M | 1.60M | 1.94M | -6.63M | -1.98M | -1.23M | -1.01M | -183.85K |
| EBITDA Ratio | 104.32% | -37.33% | -33.37% | -14.09% | -4.10% | 18.66% | -2.70% | -17.12% | 9.45% | 15.44% | -2,402.07% | -1,374.07% | 0.00% | -2,040.76% | -919.26% |
| Operating Income | -369.00K | -17.73M | -13.83M | -5.74M | -2.27M | 7.12M | -1.57M | -4.04M | 665.01K | 870.79K | -7.74M | -2.30M | -1.29M | -1.02M | -191.00K |
| Operating Income Ratio | -0.47% | -41.72% | -37.77% | -16.77% | -6.85% | 16.56% | -5.41% | -20.70% | 3.93% | 6.92% | -2,801.46% | -1,658.69% | 0.00% | -2,070.16% | -955.00% |
| Total Other Income/Expenses | 79.44M | 67.26M | -207.00K | -103.00K | -28.21K | -27.54K | -13.32K | 5.63K | 41.26K | -9.01K | 3.74K | 62.63K | -3.93K | 10.55K | 0.00 |
| Income Before Tax | 79.07M | 49.53M | -14.21M | -5.83M | -2.30M | 7.10M | -1.58M | -4.07M | 577.52K | 860.33K | -7.74M | -2.40M | -1.29M | 0.00 | 0.00 |
| Income Before Tax Ratio | 101.77% | 116.54% | -38.80% | -17.04% | -6.93% | 16.51% | -5.45% | -20.82% | 3.41% | 6.84% | -2,802.24% | -1,730.13% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 3.28M | 604.00K | -917.00K | 92.13K | -5.94K | -162.88 | 3.00K | 2.85K | 1.44K | 0.00 | 1.61K | 217.00 | -1.07K | -11.27K | 0.00 |
| Net Income | 75.80M | 35.99M | -13.29M | -5.93M | -2.29M | 7.10M | -1.58M | -4.07M | 577.52K | 860.33K | -7.74M | -2.40M | -1.29M | -1.01M | -191.00K |
| Net Income Ratio | 97.55% | 84.69% | -36.30% | -17.31% | -6.92% | 16.51% | -5.45% | -20.82% | 3.41% | 6.84% | -2,802.83% | -1,730.29% | 0.00% | -2,048.75% | -955.00% |
| EPS | 4.76 | 2.62 | -1.20 | -0.54 | -0.23 | 0.75 | -0.17 | -0.45 | 0.06 | 0.10 | -0.77 | -0.52 | -0.28 | -0.10 | -0.04 |
| EPS Diluted | 4.72 | 2.59 | -1.20 | -0.54 | -0.23 | 0.75 | -0.17 | -0.45 | 0.06 | 0.10 | -0.77 | -0.52 | -0.28 | -0.10 | -0.04 |
| Weighted Avg Shares Out | 15.92M | 13.72M | 11.04M | 11.00M | 10.00M | 9.42M | 9.10M | 9.10M | 9.08M | 8.63M | 10.00M | 4.61M | 4.61M | 10.00M | 4.61M |
| Weighted Avg Shares Out (Dil) | 16.05M | 13.88M | 11.04M | 11.00M | 10.00M | 9.42M | 9.34M | 9.10M | 9.08M | 8.63M | 10.00M | 4.61M | 4.61M | 10.00M | 4.61M |
Source: https://incomestatements.info
Category: Stock Reports